Skip to main content
. 2019 Sep 5;8(18):e012530. doi: 10.1161/JAHA.119.012530

Figure 3.

Figure 3

Propensity score–matched analysis of ticagrelor vs clopidogrel; impact on 1‐year major adverse cardiac and cerebrovascular events (MACCEs), 1‐year mortality, and bleeding events. HR indicates hazard ratio.